TRINQELA Trademark

Trademark Overview

On Sunday, December 18, 2016, a trademark application was filed for TRINQELA with the United States Patent and Trademark Office. The USPTO has given the TRINQELA trademark a serial number of 79205244. The federal status of this trademark filing is REGISTERED as of Tuesday, December 11, 2018. This trademark is owned by Can-Fite Biopharma Ltd. The TRINQELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment and prevention of rheumatoid arthritis; pharmaceutical preparations for treatment and prevention of psoriasis and skin inflammations
trinqela

General Information

Serial Number79205244
Word MarkTRINQELA
Filing DateSunday, December 18, 2016
Status700 - REGISTERED
Status DateTuesday, December 11, 2018
Registration Number5624577
Registration DateTuesday, December 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment and prevention of rheumatoid arthritis; pharmaceutical preparations for treatment and prevention of psoriasis and skin inflammations
Translation of Words in MarkThe wording "TRINQELA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 17, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCan-Fite Biopharma Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address4951778 Petah Tikva
IL
Party NameCan-Fite Biopharma Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address4951778 Petah Tikva
IL
Party NameCan-Fite Biopharma Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address4951778 Petah Tikva
IL

Trademark Events

Event DateEvent Description
Monday, April 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, May 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 17, 2017ASSIGNED TO EXAMINER
Tuesday, April 18, 2017NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 21, 2017APPLICATION FILING RECEIPT MAILED
Friday, April 21, 2017REFUSAL PROCESSED BY MPU
Friday, April 21, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 13, 2017REFUSAL PROCESSED BY IB
Wednesday, May 24, 2017ASSIGNED TO LIE
Wednesday, November 15, 2017OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Monday, November 20, 2017OPPOSITION INSTITUTED NO. 999999
Wednesday, June 14, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 17, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, November 15, 2017OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, March 19, 2019FINAL DISPOSITION PROCESSED
Friday, December 8, 2017REFUSAL PROCESSED BY IB
Wednesday, September 19, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 19, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, October 6, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 7, 2018OPPOSITION TERMINATED NO. 999999
Wednesday, November 7, 2018OPPOSITION DISMISSED NO. 999999
Wednesday, November 7, 2018TTAB RELEASE CASE TO TRADEMARKS
Tuesday, December 11, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 11, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 14, 2024TEAS SECTION 71 RECEIVED
Monday, December 11, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, March 19, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 5, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 19, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 6, 2023NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

trinqela pharmaceutical prevention treatment preparations inflammations skin rheumatoid arthritis psoriasis